Evidence map›Paper›PMID 28765116›Full record

ArticleCancer discovery2017

Janet Y Leung, William Y Kim

Open access · greenAbstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer discovery, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Janet Y LeungLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
William Y KimLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. wkim@ad.unc.edu.
University of North Carolina at Chapel Hill · US

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5M
Kinase Inhibition in Kidney CancerR01CA202053 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KIM, WILLIAM Y. · 2016 to 2020
$2.1M
The Therapeutic Potential of Targeting MYC Activity in Renal TumorigenesisR21CA194987 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LEUNG, YEE MAN JANET (JANET) · 2015 to 2016
$359k
NCI NIH HHS P30 CA016086NCI NIH HHS R01 CA202053NCI NIH HHS R21 CA194987
6 · The paper itself

Abstract

<b/> Large genome sequencing efforts have identified frequent mutations in the histone-modifying and chromatin-remodeling genes

Indexed as

AnimalsCarcinoma, Renal CellChromatin Assembly and DisassemblyDisease Models, AnimalDNA-Binding ProteinsGenetic EngineeringHistone CodeHMGB ProteinsHumansMechanistic Target of Rapamycin Complex 1MiceMice, TransgenicMutationTranscription FactorsTumor Suppressor ProteinsUbiquitin ThiolesteraseBAP1 protein, mouseDNA-Binding ProteinsHMGB ProteinsMechanistic Target of Rapamycin Complex 1Pbrm1 protein, mouseTranscription FactorsTumor Suppressor ProteinsUbiquitin ThiolesteraseVHL protein, mouseVon Hippel-Lindau Tumor Suppressor Protein

Identifiers

PMID28765116
PMCPMC7549016
OpenAlexW2741105341

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.